XML 59 R44.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Quarterly Financial Data (Unaudited) (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2015
Quarterly Financial Data |
Schedule of Quarterly Financial Information |
|  | 2015 Quarters |
|  | First |  | Second |  | Third |  | Fourth |
Net revenues |  |  |  |  |  |  |  |  |  |  |  |  |
Finished pharmaceutical products |  | $ | 50,872 |  | $ | 50,075 |  | $ | 57,902 |  | $ | 66,092 |
API |  |  | 6,014 |  |  | 3,778 |  |  | 5,966 |  |  | 10,820 |
Total net revenues |  | $ | 56,886 |  | $ | 53,853 |  | $ | 63,868 |  | $ | 76,912 |
Gross profit |  |  |  |  |  |  |  |  |  |  |  |  |
Finished pharmaceutical products |  | $ | 12,853 |  | $ | 12,634 |  | $ | 19,302 |  | $ | 29,357 |
API |  |  | 427 |  |  | 684 |  |  | (1,724) |  |  | 3,814 |
Total gross profit |  | $ | 13,280 |  | $ | 13,318 |  | $ | 17,578 |  | $ | 33,171 |
Net income (loss) |  | $ | (665) |  | $ | (6,647) |  | $ | (3,008) |  | $ | 7,533 |
Weighted-average shares used to compute net income (loss) per share |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 44,601 |  |  | 44,849 |  |  | 45,310 |  |  | 45,085 |
Diluted |  |  | 44,601 |  |  | 44,849 |  |  | 45,310 |  |  | 46,709 |
Net income (loss) per share |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | (0.01) |  | $ | (0.15) |  | $ | (0.07) |  | $ | 0.17 |
Diluted |  | $ | (0.01) |  | $ | (0.15) |  | $ | (0.07) |  | $ | 0.16 |
|  | 2014 Quarters |
|  | First |  | Second |  | Third |  | Fourth |
Net revenue |  |  |  |  |  |  |  |  |  |  |  |  |
Finished pharmaceutical products |  | $ | 45,870 |  | $ | 48,901 |  | $ | 53,729 |  | $ | 49,980 |
API |  |  | — |  |  | 102 |  |  | 5,982 |  |  | 5,897 |
Total net revenues |  | $ | 45,870 |  | $ | 49,003 |  | $ | 59,711 |  | $ | 55,877 |
Gross profit |  |  |  |  |  |  |  |  |  |  |  |  |
Finished pharmaceutical products |  | $ | 12,509 |  | $ | 14,961 |  | $ | 12,122 |  | $ | 13,132 |
API |  |  | — |  |  | 35 |  |  | (331) |  |  | (1,172) |
Total gross profit |  | $ | 12,509 |  | $ | 14,996 |  | $ | 11,791 |  | $ | 11,960 |
Net loss |  | $ | (1,619) |  | $ | (1,180) |  | $ | (5,379) |  | $ | (2,521) |
Weighted-average shares used to compute net loss per share |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 38,769 |  |  | 39,767 |  |  | 44,644 |  |  | 44,648 |
Diluted |  |  | 38,769 |  |  | 39,767 |  |  | 44,644 |  |  | 44,648 |
Net loss per share |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | (0.04) |  | $ | (0.03) |  | $ | (0.12) |  | $ | (0.06) |
Diluted |  | $ | (0.04) |  | $ | (0.03) |  | $ | (0.12) |  | $ | (0.06) |

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the quarterly financial data in the annual financial statements. The disclosure includes financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income (loss) before extraordinary items and cumulative effect of a change in accounting principle and earnings per share data. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a)-(j) -URI http://asc.fasb.org/extlink&oid=51825399&loc=d3e1280-108306 + Details
Name: | us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration